Granulocyte-macrophage colony-stimulating factor and tumor necrosis factor-[alpha] in combination is a useful diagnostic biomarker to distinguish familial Mediterranean fever from sepsis

Objective To identify potential biomarkers to distinguish familial Mediterranean fever (FMF) from sepsis. Method We recruited 28 patients diagnosed with typical FMF (according to the Tel Hashomer criteria), 22 patients with sepsis, and 118 age-matched controls. Serum levels of 40 cytokines were anal...

Full description

Saved in:
Bibliographic Details
Published inArthritis research & therapy Vol. 23; no. 1
Main Authors Koga, Tomohiro, Furukawa, Kaori, Migita, Kiyoshi, Morimoto, Shimpei, Shimizu, Toshimasa, Fukui, Shoichi, Umeda, Masataka, Endo, Yushiro, Sumiyoshi, Remi, Kawashiri, Shin-ya, Iwamoto, Naoki, Ichinose, Kunihiro, Tamai, Mami, Origuchi, Tomoki, Maeda, Takahiro, Yachie, Akihiro, Kawakami, Atsushi
Format Journal Article
LanguageEnglish
Published BioMed Central Ltd 15.10.2021
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Objective To identify potential biomarkers to distinguish familial Mediterranean fever (FMF) from sepsis. Method We recruited 28 patients diagnosed with typical FMF (according to the Tel Hashomer criteria), 22 patients with sepsis, and 118 age-matched controls. Serum levels of 40 cytokines were analyzed using multi-suspension cytokine array. We performed a cluster analysis of each cytokine in the FMF and sepsis groups in order to identify specific molecular networks. Multivariate classification (random forest analysis) and logistic regression analysis were used to rank the cytokines by importance and determine specific biomarkers for distinguishing FMF from sepsis. Results Fifteen of the 40 cytokines were found to be suitable for further analysis. Levels of serum granulocyte-macrophage colony-stimulating factor (GM-CSF), fibroblast growth factor 2, vascular endothelial growth factor, macrophage inflammatory protein-1b, and interleukin-17 were significantly elevated, whereas tumor necrosis factor-[alpha] (TNF-[alpha]) was significantly lower in patients with FMF compared with those with sepsis. Cytokine clustering patterns differed between the two groups. Multivariate classification followed by logistic regression analysis revealed that measurement of both GM-CSF and TNF-[alpha] could distinguish FMF from sepsis with high accuracy (cut-off values for GM-CSF = 8.3 pg/mL; TNF-[alpha] = 16.3 pg/mL; sensitivity, 92.9%; specificity, 94.4%; accuracy, 93.4%). Conclusion Determination of GM-CSF and TNF-[alpha] levels in combination may represent a biomarker for the differential diagnosis of FMF from sepsis, based on measurement of multiple cytokines. Keywords: Familial Mediterranean fever, sepsis, TNF-[alpha], GM-CSF, Cytokine profile
ISSN:1478-6354
1478-6362
DOI:10.1186/s13075-021-02644-2